Injective Revenue to Valuation Ratio Outpaces Solana and Ethereum
Injective (INJ) led major blockchain networks in year-to-date revenue relative to fully diluted valuation (FDV) in 2026. The platform achieved a revenue-to-FDV ratio of 0.95, placing it ahead of Solana at 0.83 and Arbitrum at 0.78. Injective's metric stood significantly higher than Ethereum at 0.11, as well as Sui and Avalanche, which both recorded 0.08. Following the metrics comparison, the INJ token rose 6.26% to $8.144.
A high revenue-to-FDV ratio indicates that a blockchain generates substantial onchain revenue relative to its potential token market valuation. Injective supplements this performance through its community buyback program, which uses generated network revenue to permanently remove INJ tokens from monthly circulation. While a strong ratio offers fundamental backing for valuation arguments, it does not guarantee token price growth, and the precise price impact of monthly buybacks remains unquantified.
Looking ahead, Injective expects to drive further revenue growth by onboarding new tokenization initiatives and launching additional products in the coming months. Market participants will watch whether these upcoming launches build sustained network revenue and whether token removals effectively translate into long-term token value.
Key points
- Injective reached a revenue-to-FDV ratio of 0.95 in 2026, outperforming Solana at 0.83 and Arbitrum at 0.78.
- Injective's ratio was more than eight times Ethereum's 0.11 and over ten times the 0.08 figures of Sui and Avalanche.
- Onchain revenue directly funds the INJ Community BuyBack, which permanently removes tokens from circulation monthly.
- The network plans to boost future revenue by launching new tokenization initiatives and financial products.
- The INJ token gained 6.26% to trade at $8.144.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What is Injective's revenue to FDV ratio?
Injective achieved a revenue to fully diluted valuation (FDV) ratio of 0.95 in 2026, placing it ahead of Solana at 0.83, Arbitrum at 0.78, and Ethereum at 0.11.
How does the INJ token buyback program work?
Onchain revenue generated by the network flows into the INJ Community BuyBack program, which permanently removes tokens from circulation on a monthly basis.
What are Injective's future growth plans?
Injective plans to expand network revenue by introducing new tokenization projects and launching additional products in the coming months.